EP4209510
MÓT-PD-L1 MÓTEFNI OG NOTKUN ÞEIRRA TIL AÐ AUKA VIRKNI T-FRUMU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.12.2009EP published:
31.1.2024EP application number:
22215991.5
EP translation filed:
20.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
7.12.2029Expiry date:
7.12.2026Next due date:
31.12.2026
Title in English:
ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTIONLanguage of the patent:
English
Timeline
Today
8.12.2009EP application
31.1.2024EP Publication
20.2.2024Translation submitted
15.3.2024Registration published
7.12.2026Expires
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
IRVING, BryanAddress:
San Francisco, 94107, US
Name:
CHEUNG, JeanneAddress:
San Francisco, 94158, US
Name:
CHIU, HenryAddress:
San Francisco, 94116, US
Name:
LEHAR, Sophie M.Address:
Montara, 94037, US
Name:
MAECKER, HeatherAddress:
South San Francisco, 94080-4990, US
Name:
MARIATHASAN, SanjeevAddress:
Millbrae, 94030, US
Name:
WU, YanAddress:
Foster City, 94404, US
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221, Hafnarfirði,
Priority
Number:
121092 PDate:
9.12.2008Country:
US
Supplementary protection
SPC number:
SPC473
Classification
Categories:
C07K 16/28, A61P 35/00, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 22.11.2024
Expires: 7.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.12.2025
Expires: 7.12.2026
Payer: Árnason Faktor ehf.